Skip to main content

Table 2 General characteristics and genotype distribution

From: Interactions between genetic variants involved in the folate metabolic pathway and serum lipid, homocysteine levels on the risk of recurrent spontaneous abortion

Variable

Case (n = 403)

Control (n = 342)

t/χ 2

p

Ethnic

0.43

0.805

 Han

198 (49.1)

160 (46.8)

  

 Zhuang

178 (44.2)

159 (46.5)

  

 Minority

27 (6.7)

23 (6.7)

  

Education level

1.20

0.550

  ≤ 9 years of school

157 (39.0)

120 (35.1)

  

 10–12 years of school

83 (20.6)

74 (21.6)

  

  ≥ 13 years of school

163 (40.4)

148 (43.3)

  

Gynecological surgery history

1.09

0.298

 Yes

42 (10.4)

28 (8.2)

  

 No

361 (89.6)

314 (91.8)

  

Current smoking

0.10

0.756

 Yes

7 (1.7)

7 (2.0)

  

 No

396 (98.3)

335 (98.0)

  

Passive smoking history

0.003

0.960

 Yes

89 (22.1)

75 (21.9)

  

 No

314 (77.9)

267 (78.1)

  

Drinking history

0.04

0.847

 Yes

43 (10.7)

38 (11.1)

  

 No

360 (89.3)

304 (88.9)

  

X-ray contact history

0.52

0.596

 Yes

1 (0.2)

2 (0.6)

  

 No

402 (99.8)

340 (99.4)

  

Chemical exposure history

3.41

0.065

 Yes

1 (0.2)

5 (1.5)

  

 No

402 (99.8)

337 (98.5)

  

Folic acid supplement

3.91

0.048

 Yes

131 (32.5)

135 (39.5)

  

 No

272 (67.5)

207 (60.5)

  

Multivitamin supplement

1.38

0.240

 Yes

17 (4.2)

9 (2.6)

  

 No

386 (95.8)

333 (97.4)

  

Age, year

29.58 ± 5.48

29.88 ± 5.28

0.85

0.673

Folic acid, nmol/L

32.45 ± 8.86

34.35 ± 18.98

−1.79

0.072

Vitamin B12, pg/ml

352.70 ± 124.01

347.48 ± 124.10

0.57

0.567

Homocysteine, umol/L

11.89 ± 4.62

11.20 ± 3.40

2.36

0.018

Total protein, g/L

72.17 ± 6.79

70.67 ± 9.47

2.52

0.012

Total cholesterol, mmol/L

5.43 ± 20.10

4.42 ± 1.91

0.92

0.359

Triglyceride, mmol/L

1.06 ± 0.69

1.03 ± 0.55

0.62

0.536

High-density lipoprotein cholesterol, mmol/L

1.66 ± 0.38

1.73 ± 0.38

−2.38

0.018

Low-density lipoprotein cholesterol, mmol/L

2.61 ± 0.77

2.41 ± 0.68

3.62

< 0.001

Fasting glucose, mmol/L

4.93 ± 0.38

4.92 ± 0.19

0.15

0.884

Fasting insulin, pmol/L

71.13 ± 14.82

67.60 ± 13.84

3.35

0.001

HOMR-IR

2.23 ± 0.45

2.12 ± 0.41

3.48

0.001

IL6, pg/ml

75.12 ± 311.20

40.58 ± 202.95

1.82

0.069

TNFα, pg/ml

28.40 ± 92.16

18.28 ± 31.02

2.08

0.038

MTHFR C677T

 CC

213 (52.9)

253 (74.0)

35.24

< 0.001

 CT

153 (38.0)

78 (22.8)

19.87

< 0.001

 TT

37 (9.2)

11 (3.2)

10.92

0.001

 C allele

579 (71.8)

584 (85.4)

–

–

 T allele

227 (28.2)

100 (14.6)

39.62

< 0.001

MTHFR A1298C

 AA

231 (57.3)

221 (64.6)

4.13

0.042

 AC

144 (35.7)

102 (29.8)

2.92

0.088

 CC

28 (6.9)

19 (5.6)

0.61

0.436

 A allele

606 (75.2)

544 (79.5)

–

–

 C allele

200 (24.8)

140 (20.5)

3.97

0.046

MTRR A66G

 AA

225 (55.8)

226 (66.1)

8.14

0.004

 AG

148 (36.7)

100 (29.2)

4.67

0.031

 GG

30 (7.4)

16 (4.7)

2.44

0.118

 A allele

598 (74.2)

552 (80.7)

–

–

 G allele

208 (25.8)

132 (19.3)

8.90

0.003

  1. HOMA-IR Homeostatic model assessment of insulin resistance, IL6 Interleukin 6, TNFα Tumor necrosis factor α